CHRONIC MULTIPLE MYELOMA

Multiple myeloma is a cancer of plasma cells, a type of white blood cell normally responsible for producing antibodies

In multiple myeloma, collections of abnormal plasma cells accumulate in the bone marrow, where they interfere with the production of normal blood cells. Most cases of multiple myeloma also feature the production of a paraprotein—an abnormal antibody which can cause kidney problems. Bone lesions and hypercalcemia (high blood calcium levels) are also often encountered.Multiple myeloma is diagnosed with blood tests (serum protein electrophoresis, serum free kappa/lambda light chain assay), bone marrow examination, urine protein electrophoresis, and X-rays of commonly involved bones.

Multiple myeloma is considered to be incurable but treatable. Remissions may be induced with steroids, chemotherapy, proteasome inhibitors, immunomodulatory drugs such as thalidomide or lenalidomide, and stem cell transplants. Radiation therapy is sometimes used to reduce pain from bone lesions

Contact Details

IKRIS Pharma Network Pvt. Ltd.
905 , I - Thum Business Park,
Plot No. A-40, Unit No. 5, Tower A,
Sector-62, Noida – 201301 (India)

Phone No.- +91-120–2400370.
M: + 91 8130290915

WhatsApp: +91 8130290915
QQID:- 1927411523
Skype ID: praveen.sikri
E:info@ikrispharmanetwork.com

Query Form

CHRONIC MULTIPLE MYELOMA MEDICATIONS

KYPROLIS( Carfilzomib )

Kyprolis® (carfilzomib) for Injection, a proteasome inhibitor, is approved for the treatment of patients with multiple myeloma who have received at least two prior therapies, including bortezomib and an immunomodulatory agent,

More Details

BELEODAQ (belinostat) injection

Beleodaq is a histone deacetylase inhibitor indicated for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL).

Learn More

NINLARO (Ixazomib) Capsules

NINLARO is indicated in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received at least one prior therapy.

Learn More

DARZALEX (daratumumab)

DARZALEX is a human CD38-directed monoclonal antibody indicated for the treatment of patients with multiple myeloma who have received at least three prior lines of therapy including a proteasome inhibitor (PI) ...

Learn More

FARYDAK panobinostat 10 mg Capsules

FARYDAK panobinostat is a prescription medicine used, in combination with bortezomib and dexamethasone, to treat people with a type of cancer called multiple myeloma after at least 2 other types of treatment have been tried.

Learn More

EMPLICITI (elotuzumab) for injection

EMPLICITI is a SLAMF7-directed immunostimulatory antibody indicated in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received one to three prior therapies.

Learn More

Zykadia (ceritinib) capsules

ZYKADIA is a prescription medicine that is used to treat people with non - small cell lung cancer (NS CLC) that is caused by a defect in a gene called anaplastic lymphoma kinase (ALK)...

Learn More